The QualityStocks Daily Monday, April 2nd, 2018

Today's Top 3 Investment Newsletters

Trader Power News (SLS) +150.72%

MarketBeat (HEAT) +100.00%

CannabisNewsWire (AVOP) +29.38%

The QualityStocks Daily Stock List

Marina Biotech, Inc. (MRNA)

Stock Twits, The Street, MicroCap Daily, Street Insider, Barchart, YCharts, OTC Markets, Zacks, MarketWatch, InvestorsHub, Amigo Bulls, and Marketbeat reported on Marina Biotech, Inc. (MRNA), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Marina Biotech, Inc. centers on the development and commercialization of inventive therapeutics for hypertension, arthritis, pain, and oncology. The Company’s commercial product is Prestalia®. It is approved by the US FDA (Food and Drug Administration) for the treatment of hypertension. Prestalia® is being commercialized via the DyrctAxess platform. A biopharmaceutical enterprise, Marina Biotech has its corporate office in City of Industry, California.

The Company is developing and commercializing late stage, non-addictive pain therapeutics. Its mission is to provide effective and patient centric treatment for hypertension. This includes resistant hypertension. Marina Biotech is working to create a universal platform for the effective treatment of hypertension and for the distribution of fixed dose combination [FDC] hypertensive drugs such as Prestalia® and those in its pipeline.

Prestalia® contains perindopril arginine, an angiotensin converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker. Prestalia® is indicated for the treatment of hypertension, to lower blood pressure.

Prestalia® may be used in patients whose blood pressure is not sufficiently controlled on monotherapy. Prestalia® may be used as initial therapy in patients likely to need multiple drugs to achieve blood pressure goals.

Prestalia® is available to physicians and patients by way of bpCareConnect. This is a hypertension management program offered by Symplmed.

bpCareConnect (Powered by Symplmed’s DyrctAxess™ technology) is a patient membership program. This program caps blood pressure medication costs, provides monitoring devices, offers online tracking tools, and ships directly to the patient.

Marina Biotech is also developing and commercializing late stage, non-addictive pain therapeutics. The design of its ‘next-generation of celecoxib,’ including IT-102 and IT-103, are to control the dangerous side-effects of edema, which prohibit the drug from being prescribed at higher doses.

These have the potential of replacing opioids and fighting the opioid epidemic. IT-102 and IT-103 are Marina Biotech’s next generation celecoxib for management of arthritis pain.

This past January, Marina Biotech announced that it entered into a binding agreement with Autotelic Bio, Inc., to enter into a license of Marina Biotech’s IT-103 clinical program, for exclusive development and marketing outside of the U.S. and Canada.

With this agreement, Autotelic Bio will obtain a perpetual license to have the right and responsibility to commence clinical development of IT-103 for marketing approval in South Korea and territories outside of the U.S. and Canada.  With the agreement, Marina Biotech will be entitled to the clinical trial data and any enhancements and inventions developed by Autotelic Bio during this process, and also royalties on sales.

Under the agreement, Marina Biotech retains all rights and territories to IT-103 as non-addictive opioid replacement for extreme pain and treatment for familial adenomatous polyposis (FAP). Autotelic Bio is a Korean headquartered biotechnology company.

In February, Marina Biotech announced more progress with its FDA-Approved Prestalia® hypertension drug, with the issuance of a new and independent publication on Prestalia®:  Elliott WJ and Bistrika EA (2018) Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation. Expert Opin Drug Saf. 17:207-216.

Dr. Vuong Trieu, Executive Chairman of Marina Biotech, said, “The Elliot and Bistrika publication highlights the impressive safety and efficacy profile of Prestalia, a profile which includes a reduction in cardiovascular events. It is data and analysis like this, along with the continued progress of the team at Marina that make me confident that Prestalia is well positioned for a successful launch.

Marina Biotech, Inc. (MRNA), closed Monday's trading session at $1.47, up 5.00%, on 670 volume with 5 trades. The average volume for the last 60 days is 2,458 and the stock's 52-week low/high is $1.10/$5.00.


AXIM Biotechnologies, Inc. (AXIM)

CFN Media Group, Promotion Stock Secrets, TopPennyStockMovers, and SmallCapVoice reported beforehand on AXIM Biotechnologies, Inc. (AXIM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

AXIM Biotechnologies, Inc. is a biotechnology company concentrating on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The Company discovers and brings to market unique solutions by way of research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. Medical Marijuana, Inc. (MJNA) is a major investor in AXIM. OTCQB-listed, AXIM Biotechnologies is based in New York, New York.

The Company’s focus is on innovative proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is currently no effective treatment. AXIM is advancing its patented controlled-release cannabinoid gum in studies encompassing several indications.

AXIM’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants. The Company also has its CanChew+ 50®, which contains 50 mg of CBD. This product is undergoing clinical trials in patients with IBS (Irritable Bowel Syndrome).

Additionally, AXIM Biotechnologies’ pipeline of Intellectual Property (IP) protected cannabinoid-based products includes MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. It is the world’s first patented cannabinoid controlled-release chewing gum.

The Company’s IP portfolio now includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain, and 15 patent applications in different stages of approval.

At the end of February 2018, Medical Marijuana, Inc. (MJNA) announced that its major investment company AXIM Biotechnologies successfully executed its first-ever proprietary current good manufacturing practices (cGMP) methodology in the extraction and microencapsulation of cannabinoid molecules for an array of pharmaceutical delivery formats from cGMP-produced medicinal cannabis.

This breakthrough makes AXIM the only Company globally with the ability to harness the proprietary procedure and provide Active Pharmaceutical Ingredients (APIs) of such purity from naturally extracted cGMP sources.

AXIM Biotechnologies, Inc. (AXIM), closed Monday's trading session at $3.65, up 7.20%, on 37,815 volume with 155 trades. The average volume for the last 60 days is 31,616 and the stock's 52-week low/high is $3.24/$15.14.


GripeVine, Inc. (GRPV)

MarketWatch, InvestorsHangout, InvestorsHub, Morningstar, and Stockhouse reported on GripeVine, Inc. (GRPV), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

GripeVine, Inc. is a company focusing on leading the revolution of social customer service. The Company is a proprietary complaint-resolution platform for the facilitation and management of social customer service through centralized communication, rating, and review tools. It has a highly scalable and sustainable growth model. GripeVine is based in Oakville, Ontario.

The Company’s mission is to establish itself as a worldwide leader in social consumer resolution and relationship management. It works to accomplish this through providing businesses strong tools to manage their social presence while providing consumers with tangible resolution results and a social engine.

GripeVine has a platform where, as the Company states, all sides can be heard. It has a user-friendly social CRM (Customer Relationship Management) platform for users to engage on.

The emphasis is on turning negative experiences into positive outcomes. Consumers with legitimate customer service complaints can post it (plant a gripe) and connect with companies who subsequently can interact with their customers on a level playing field to find a harmonious resolution. 

GripeVine provides a thriving social engine for consumers and premier back end tools for businesses. GripeVine develops, owns, and operates social customer relations applications on desktop and mobile computing platforms.

The Company has unique patents. These patents drive a flourishing community and provide businesses first-rate control over their social public image.

The GripeVine Proprietary Process helps consumers achieve resolutions while enabling businesses to improve consumer loyalty.  The Company’s platform includes the handling of ratings, reviews, and complaint resolution statuses. This is while offering data collection features including scoring, polling, comments, voting, and credibility points – all with the goal of creating a home for connections, resolution, business improvement, and loyalty enhancement.

High profiles companies and localized SME’s (small and medium-sized enterprises) use GripeVine. The Company expedites the resolution process between consumers and businesses. In essence, GripeVine creates a fair space for business and consumers to interact.

GripeVine, Inc. (GRPV), closed Monday's trading session at $0.24, up 4.35%, on 12,500 volume with 2 trades. The average volume for the last 60 days is 9,835 and the stock's 52-week low/high is $0.065/$1.00.


REGI U.S., Inc. (RGUS)

Marketwired, MarketWatch, and Stockhouse reported previously on REGI U.S., Inc. (RGUS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

REGI U.S., Inc., via its subsidiary, RadMax Technologies, Inc., engages in the design and development of axial vane-type rotary engines, known as the RadMax rotary technology, used in the design of engines, compressors, and pumps. RadMax Technologies is developing for commercialization manifold improved axial vane type rotary devices utilizing its Patented RadMax™ Rotary Technology. OTCQB-listed, REGI U.S. has its head office in Spokane, Washington.

The RadMax™ Rotary Technology allows for pioneering designs of lightweight and high efficiency engines, compressors, pumps, as well as other devices. One current prototype is The RadMax™ engine. It has only two innovative moving parts, the vanes (up to 12) and the rotor, versus the 40 moving parts in a basic four-cylinder piston engine.

The unique design makes it possible to produce up to 24 continuous power impulses per one rotation, which is vibration-free and very quiet. In addition, the RadMax™ engine has a number of capabilities permitting it to operate on fuels such as gasoline, natural gas, hydrogen, propane, and diesel.

REGI U.S.’s objective is to license RadMax technology and/or participate in joint ventures (JVs) to manufacture RadMax products for specific applications. Market segments that could benefit from RadMax technology include (but are not limited to) transportation, aerospace, air conditioning and refrigeration, oil and gas production and distribution, power generation, marine, and military markets.

This past January, the Board of Directors of REGI U.S. and its wholly-owned subsidiary, RadMax Technologies announced the achievement of a significant milestone in the development of the RadMax prototype gas expander. Earlier testing of the RadMax prototype gas expander with compressed air produced predicted torque and power generation at all tested speeds.

In the tests, torque produced by the RadMax expander was used to generate measured electric power via the use of a belt driven alternator connected to an adjustable electrical load. Satisfactory start-up torque was produced by the expander to easily self-start the unit and the alternator. Collected inlet and outlet pressures and temperatures confirmed that the torque created was because of the desired gas expansion process.

Furthermore, in February, The Board of REGI U.S. and RadMax Technologies announced that a provisional patent application was filed with the U.S. patent office (USPTO) for the use of RadMax two-phase compressors and expanders to boost the efficiency of Rankine cycle steam electricity generation plants.

Moreover, last month, The Board of Directors of REGI U.S and RadMax Technologies announced that a provisional patent application was filed with the USPTO for the use of RadMax two-phase compressors and expanders to boost the efficiency of air conditioning and refrigeration cycles.

REGI U.S., Inc. (RGUS), closed Monday's trading session at $0.12, even for the day, on 31,400 volume with 9 trades. The average volume for the last 60 days is 42,452 and the stock's 52-week low/high is $0.07/$0.30.


Tower One Wireless Corp. (TOWTF)

Stockhouse, Zacks, Insider Financial, OTC Markets, YCharts, The Street, Marketwired, Trading View, Investopedia, Investors Hangout, Emerging Growth, Barchart, Stock Syndicate, InvestorsHub, MarketWatch, 4-Traders, and Dividend Investor reported on Tower One Wireless Corp. (TOWTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Tower One Wireless Corp.’s corporate mission is to own and operate high-quality cellular network infrastructure sites in South American markets, which are experiencing strong usage growth. The Company concentrates mainly on constructing towers in municipalities where there is limited or no cellular coverage. Founded in 2015, Tower One Wireless has its head office in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

A team of telecom and finance professionals with a long history in the telecommunications and wireless infrastructure business operates Tower One Wireless. At present, the Company is centered on 4G & 5G LTE infrastructure expansion in Latin America.

Tower One Wireless builds, owns, as well as leases a portfolio of wireless infrastructure assets to wireless carriers on long term contracts. In Argentina and Colombia, the Company has an increasing portfolio of existing tower assets.

Regarding Services, Tower One Wireless offers Tower Construction, Site Acquisition and Zoning, Staffing, and RF and Technical Services and also Electrical Services.

This past February, Tower One Wireless announced its intention to spin-out its 70 percent owned subsidiary, Tower Construction & Services Company (TCTS) or its 70 percent interest in TCTS, as a separate operating entity, to create a stand-alone publicly traded company. Based in Miami, Florida, TCTS actively operates in numerous States across the eastern U.S.

Mr. Alejandro Ochoa, Tower One Wireless’ Chief Executive Officer, stated, “This strategic spin-out will provide Tower One shareholders with additional equity exposure in the growing telecom sector. As well, it will allow Tower One’s management team to be focused on its core business of providing cell towers to mobile network operators in Latin America. This business has seen strong growth, in Colombia and Argentina, along with new opportunities in Mexico.”

Last week, Tower One Wireless announced that it entered into an agreement to acquire a 100 percent interest in Process Cellular, Inc. (ProCell) as a wholly-owned subsidiary. ProCell has been operating out of Southern California for more than two decades as a turnkey general contractor, which specializes in the telecom industry & structural engineering/design.

In addition, ProCell is an approved contractor for American Tower and Crown Castle that operate worldwide and throughout South America. This strategic acquisition gives Tower One subsidiary Tower Construction and Technical Services (TCTS) major exposure to the California and Arizona markets.

Furthermore, last week, Tower One Wireless announced it has retained Mr. John Logiudice, a telecommunications senior executive with greater than 20 years of experience with Ericsson and Sprint-Nextel, to lead its Tower Services division. Mr. Logiudice will directly supervise the earlier announced spin-out of Tower One’s tower services subsidiary comprising greater than $17 million USD in 2017 Revenue.

Tower One Wireless Corp. (TOWTF), closed Monday's trading session at $0.1921, down 5.35%, on 907,745 volume with 179 trades. The average volume for the last 60 days is 83,673 and the stock's 52-week low/high is $0.13/$0.3256.


AEON Global Health Corp. (AGHC)

Amigo Bulls, Stockwatch, Simply Wall St, Zacks, Stockflare, Dividend Investor, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stockopedia, Penny Stock Hub, Investing, Stock Target Advisor, and Investors Hangout reported on AEON Global Health Corp. (AGHC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Based in Gainesville, Georgia, AEON Global Health Corp., together with its subsidiaries, provides diverse clinical laboratory testing services in the U.S. It offers diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, and Health Technology Applications. Established in 2011, the Company previously went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. this past January.

The name change is part of AEON’s broader rebranding effort. It directly reflects its growth initiatives to enhance its set of service offerings and to introduce its growing variety of services to customers in foreign markets. This includes Latin America and the Middle East.

The Company is the fastest growing clinical lab and healthcare services organization in the United States. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results.

AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface.

Inscrybe® permits physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or through electronic fax instead of transferring paper.

Concerning Telehealth services, the design of the Company’s Telehealth Solutions are to improve outcomes and lessen hospital readmission through helping clinicians closely monitor patients with chronic illnesses such as CHF, COPD and Diabetes.

This past January, AEON Global Health announced that it agreed with Sabal Therapeutics, LLC to be the main laboratory marketer of Naprosyn®,   the branded naproxen oral suspension USP. With this agreement, AEON Global Health will become the exclusive clinical laboratory marketing representative of Sabal. It will market the drug alongside of its industry-leading drug monitoring service.

Therefore, this will provide physicians with an integrated, non-opiate solution for pain management.  Headquartered in Athens, Georgia, Sabal Therapeutics is a pharmaceutical commercialization services company.

Fundamentally, AEON Global Health’s chief business emphasis is offering a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information.

The Company is an innovator in the genomic testing area. AEON has a wide-ranging menu of genetic tests and a pipeline of additional molecular-based tests in development. AEON Global Health provides post contract customer support services.

AEON Global Health Corp. (AGHC), closed Monday's trading session at $1.20, up 10.09%, on 5,344 volume with 5 trades. The average volume for the last 60 days is 2,482 and the stock's 52-week low/high is $0.40/$2.33.


Indoor Harvest Corp. (INQD)

OTPicks, Penny Stock General, CFN Media Group, Cannabis Financial Network News, MassiveStockProfits, Orbit Stocks, SmallCapVoice, Fast Money Alerts, Stock Shock and Awe, and PennyPickAlerts reported earlier on Indoor Harvest Corp. (INQD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Indoor Harvest Corp. is a developer of personalized cannabis medicines. In addition, the Company is a provider of advanced cultivation technology, methods, and processes. Indoor Harvest provides the cannabis industry production platforms for Building Integrated Agriculture (BIA) production. Indoor Harvest is headquartered in Houston, Texas.

Indoor Harvest entered into an Agreement and Plan of Merger with Alamo CBD, on August 4, 2017. The plan completed a six-month process of work, transitioning the Company into a producer of cannabis for research and pharmaceutical development. Indoor Harvest’s patent pending aeroponic methods allow for the production of chemically consistent, contaminate free cannabis, economically at scale. Indoor Harvest is currently a pending applicant via its acquisition of Alamo CBD, to produce cannabis, under the Texas Compassionate Use program. In addition, Indoor Harvest is preparing an application to produce cannabis under the Controlled Substance Act.

Additionally, Indoor Harvest is finalizing plans with investors and developers to build facilities in the States of Arizona and Colorado. Indoor Harvest’s intention is to produce revenue from its developed facilities by way of leasing and licensing of its technology and methods.

Zoned Properties, Inc. and Indoor Harvest announced this past October that the two companies entered into a Binding Letter of Intent (LOI) outlining three independent agreements to complete research and development projects for licensed medical marijuana facilities to be situated in Tempe, Arizona, Parachute, Colorado, and Stockdale, Texas or other location to be determined after approval of a provisional license under the Texas Compassionate Use program.

Zoned Properties is a strategic real estate development firm. Its chief mission is to identify, develop, and lease sophisticated, safe and sustainable properties in developing industries, including the licensed medical marijuana industry.

In October, Indoor Harvest also announced that it chose Harvest Air, LLC as its HVAC partner to develop integrated solutions for precision cannabis production. Harvest Air has a patent pending HVAC system. It uses air-to-air economization to allow producers the ability to use outside air to cool and dehumidify the cultivation environment, without bringing that outside air into the cultivation environment. The result is precise control of the cultivation environment. This is with the lowest operational cost among all other qualified systems.

Harvest Air is a developer of HVAC technology specific to the Controlled Environment Agriculture (CEA) industry, focused around its patent pending air-to-air economization system. Recently, Indoor Harvest announced that it chose BIOS Lighting as its exclusive LED development partner for its efforts in Arizona, Colorado, and Texas. The two Companies plan to collaborate, alongside Harvest Air, towards the development of a fully integrated platform.

The design of this platform is to provide producers the ability to manage and record phenotypic plasticity in the Cannabis plant. Biological Innovations and Optimization Systems, LLC (BIOS) is a recognized innovator in the biological application of LED lighting.

Indoor Harvest Corp. (INQD), closed Monday's trading session at $0.126, up 17.76%, on 62,376 volume with 20 trades. The average volume for the last 60 days is 73,711 and the stock's 52-week low/high is $0.10/$0.50.


ZIVO Bioscience, Inc. (ZIVO)

RedChip and Ceocast News reported earlier on ZIVO Bioscience, Inc. (ZIVO), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

ZIVO Bioscience, Inc.’s dedication is to the development and commercialization of nutritional compounds and bioactive molecules derived from its proprietary algal strains. Additionally, the Company engages in the development of natural bioactive compounds for use as dietary supplements and food ingredients, and biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically centered on autoimmune and inflammatory response modulation.

Listed on the OTC Markets’ OTCQB, ZIVO Bioscience is based in Keego Harbor, Michigan. The Company’s wholly-owned subsidiary is WellMetris, LLC.

ZIVO Bioscience is re-inventing itself as a licensor of internally developed intellectual property (IP), which includes its proprietary algae cultures, in addition to IP secured via strategic acquisitions. The Company is a biotech/agtech R&D company involved in the commercialization of nutritional and medicinal products derived from proprietary algal strains

ZIVO Bioscience works to totally harness the beneficial effects of its natural bioactive agents and make them affordable and readily available in a useful and convenient form.  The Company has more recently continued to concentrate almost exclusively on dairy cow applications for its proprietary algal biomass, extracts and any high-value bioactive compounds thereof. This is while developing the business case and production scale-up to cultivate and productize the algal biomass. 

ZIVO Biosceince’s core IP consists of the algae culture itself, the patented process of producing that culture, and the bioactive compounds or molecules that can be extracted, as well as the application of that culture or extract in supporting health maintenance and longevity.

The Company’s plan is to approach the near-term markets first: animal applications, human food ingredients and human dietary supplements. This is while laying the base for the more complex and longer-term opportunities in the medicinal and pharmaceutical market verticals.

Last week, ZIVO Bioscience announced that Mr. William P. Pfund joined the Company as its new Vice-President of Research & Development. Mr. Pfund will manage overall research goals and compliance initiatives. He will also help transition ZIVO’s ongoing R&D into marketable products and licenses.

Dr. Amy Steffek will continue in her role as Director, Research & Development. She will concentrate mainly on conducting the different tests, studies, and experiments, and manage the data and findings, which populate the ZIVO intellectual property (IP) portfolio. In addition, Dr. Paul Wooley will continue in his role as consulting immunologist.

ZIVO Bioscience, Inc. (ZIVO), closed Monday's trading session at $0.1096, up 11.84%, on 9,850 volume with 7 trades. The average volume for the last 60 days is 145,686 and the stock's 52-week low/high is $0.0502/$0.1469.


ARC Group, Inc. (ARCK)

Zacks, YCharts, Capital Cube, Barchart, Insider Monkey, OTC Markets, InvestorsHub, MarketWatch, Stockhouse, GuruFocus, 4-Traders, and The Street reported on ARC Group, Inc. (ARCK), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

ARC Group, Inc. is the owner, operator, and franchisor of the Dick’s Wings & Grill concept. Dick’s Wings has 17 restaurants in Florida and five restaurants in Georgia. Dick's Wings is actively offering franchise opportunities in Florida, Georgia, Alabama, Louisiana, North Carolina and South Carolina. Dick’s Wings & Grill® restaurants provides its customers a casual, family-fun restaurant environment designed to appeal to families and sports fans alike.

Established in 2000, ARC Group is based in Jacksonville, Florida. The Company was formerly known as American Restaurant Concepts, Inc. It changed its name to ARC Group, Inc. in June 2014. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s Dick’s Wings features its award-winning chicken wings, hog wings, and duck wings spun in its signature sauces and seasonings. Moreover, it offers its own proprietary line of craft beers under the name “Dick’s Craft Beers”. In addition, Dick’s Wings has two concession stands at EverBank Field, home of the National Football League’s (NFL’s) Jacksonville Jaguars.

Dick's Wings offers a variety of boldly-flavored menu items. These are highlighted by its award-winning, Buffalo, New York-style chicken wings and hog wings and its Dick's Blingz® boneless chicken wings that have 365 flavors.

Dick’s Wings also offers customers an array of fresh sandwiches, burgers, wraps, salads, and signature waffle fries. The restaurants are an elevated sports-themed environment. They include flat screen TVs positioned throughout each facility and children's areas filled with video games and other types of children's entertainment.

Today, ARC Group announced financial results for its 2017 Fiscal Year (FY) highlighted by record Revenue, Net Income and Cash Flows from Operations. For the Company’s FY 2017, Revenue rose 248 percent to $4,445,663 from $1,275,448 for 2016. Loss from Operations decreased $728,611 to $84,614 during 2017 versus $813,225 during 2016.

Net Income was $344,740, or $0.05 per share, during 2017 versus a Net Loss of $813,713, or $0.12 per share, during 2016. Adjusted Net Income per Share was $0.06 for 2017 and 2016. Cash Flows from Operations was $248,345 during 2017 versus Cash Used by Operations of $10,087 during 2016. This represents an improvement of $258,432.

In 2017, ARC Group entered into a new partnership with the National Football League’s (NFL's) Jacksonville Jaguars. With this partnership, it will serve as a sponsor of the Jaguars for the next five football seasons under the designation "Official Wings of the Jacksonville Jaguars". It will also operate two concession stands at TIAA Bank Field (previously EverBank Field).

ARC Group, Inc. (ARCK), closed Monday's trading session at $1.70, up 21.43%, on 1,130 volume with 5 trades. The average volume for the last 60 days is 768 and the stock's 52-week low/high is $0.55/$2.25.


The QualityStocks Company Corner

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Blockchain Technology Brings Efficiency to Diverse Businesses," featuring Global Payout, Inc. (GOHE). To hear the NetworkNewsAudio version, visit To read the original editorial, visit

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed Monday's trading session at $0.0139, up 1.83%, on 10,440,484 volume with 228 trades. The average volume for the last 60 days is 10,968,292 and the stock's 52-week low/high is $0.0123/$0.16.

Recent News


Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Consorteum Holdings, Inc. (OTCPK:CSRH), a software development company and mobile device solutions provider, today announced that its wholly owned subsidiary, 359 Mobile Inc. (“359”), will release its first global predictive analytics mobile offering. This product will be dedicated to the global sport of Cricket.

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed Monday's trading session at $0.0011, off by 8.33%, on 18,485,335 volume with 60 trades. The average volume for the last 60 days is 5,012,335 and the stock's 52-week low/high is $0.0005/$0.0085.

Recent News


PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring PreveCeutical Medical Inc. (OTCQB:PRVCF) (CSE:PREV) (FSE:18H), a client of CNW and health sciences company that develops innovative preventive therapies utilizing organic and nature identical products. To view the full publication, titled “Cannabis Continues to Provide Progress in Medical Sector,” visit:

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed Monday's trading session at $0.293, off by 0.03%, on 23,081 volume with 23 trades. The average volume for the last 60 days is 23,504 and the stock's 52-week low/high is $0.01/$0.80.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.032, off by 5.88%, on 4,136,196 volume with 260 trades. The average volume for the last 60 days is 7,656,739 and the stock's 52-week low/high is $0.0132/$0.415.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is positioning itself to make the most of the Canadian cannabis industry’s anticipated spike. To view the full article, visit:

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed Monday's trading session at $0.739, off by 1.47%, on 189,105 volume with 160 trades. The average volume for the last 60 days is 99,457 and the stock's 52-week low/high is $0.125/$0.8612.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

Positive assay results from exploratory drill holes taken from a prospective zone of cobalt mineralization near a mine owned by First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) are seen as ‘significantly promising’. Also today, NetworkNewsWire released a report on the company detailing how FTSSF is able to evade the negative publicity regarding mining African cobalt since the company’s cobalt properties are located in North America. To view the full article, visit:

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed Monday's trading session at $0.7843, off by 1.20%, on 78,120 volume with 84 trades. The average volume for the last 60 days is 240,433 and the stock's 52-week low/high is $0.3148/$1.3041.

Recent News


MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF).

MGX Minerals Inc. (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is pleased to announce that the Spring Drill program at the Company’s Case Lake Lithium JV (“Case Lake”) will commence in May. Spring/Summer drilling will total 8,000 meters followed by an additional 7,000 meters of planned drilling in the Fall. There have been 8,400 meters of drilling completed at Case Lake to date.

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That’s a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it’s being pulled up to the surface. The company’s petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the “white gold” of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral’s cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies.

MGX Minerals Inc. (MGXMF), closed Monday's trading session at $0.761, off by 0.52%, on 218,284 volume with 87 trades. The average volume for the last 60 days is 297,615 and the stock's 52-week low/high is $0.543/$1.5835.

Recent News


IEG Holdings Corp. (IEGH)

The QualityStocks Daily Newsletter would like to spotlight IEG Holdings Corp. (IEGH).

Amid the world of quick personal lending, IEG Holdings Corp. (OTCQB: IEGH) is making a name for itself as a company that offers loans to the underbanked household market while working to keep its own risk at a low level. IEG Holdings is a fintech online lender that offers $5,000 and $10,000 unsecured loans on an installment basis.

IEG Holdings Corp. (OTCQB: IEGH) is a publicly traded, global leader in consumer finance providing small-sized online personal loans in the United States via a state-licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand “Mr. Amazing Loans.” Based in Las Vegas, the company originates consumer loans in 20 states: Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Missouri, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia and Wisconsin via its online platform and distribution network. IEGH is a licensed direct lender with state licenses and/or certificates of authority to lend in each state and offers all loans within the prevailing statutory rates.

Mr. Amazing Loans is a leading FinTech company specializing in dedicated loan amounts of $5,000 to $10,000 offered directly to consumers through an easy-to-use website known for its professional interaction with applicants. All loans are originated, processed and serviced out of the company’s Las Vegas corporate offices, eliminating the need for physical locations in each state where IEGH is licensed to conduct business. The company’s loans are unsecured consumer loans that mature in five years at interest rates significantly less than those of payday lenders. Consumers are able to receive same-day processing and are assured of no hidden or additional fees, no prepayment penalty, with repayment and interest rates fixed at 29.9% or less Annual Percentage Rate (APR) for the life of the loan.

The Center for Responsible Lending states the typical payday loan has rates ranging from 391% to 521% APR on loans that typically range from $100 to $1,000. Conversely, Mr. Amazing Loans’s terms are designed with low fixed repayments to fit into consumer budgets with the added goal of helping clients reach a stronger financial position. Loan funds are deposited directly into an approved consumer’s checking account and may be approved the same day after necessary application documentation is received.

IEG Holdings has also incorporated Investment Evolution Crypto, LLC., a 100 percent owned subsidiary, and tasked the new company with exploring business opportunities in the cryptocurrency/blockchain industry. Specifically, the subsidiary company will explore the legalities and economic risks of entering into a joint venture with IEGH’s other 100 percent owned subsidiary company, Investment Evolution Corporation dba Mr. Amazing Loans. Among the questions to be answered during this development planning stage are whether Mr. Amazing Loans should accept repayment of customer loans in the form of leading crypto/blockchain currencies such as Bitcoin, provide the equivalent of USD $5,000 and $10,000 loans to consumers in cryptocurrencies, and potentially create and issue an Investment Evolution cryptocurrency.

Paul Mathieson, IEG Holdings’ chairman and Chief Executive Officer, has over 19 years of finance industry experience in lending, funds management, stock market research and investment banking. He has been a member of the board of directors at IEGH since 2012 and of its subsidiary since 2009. Mathieson founded IEG Holdings Limited in Sydney, Australia, launching the Amazing Loans business in that country in 2005 and then in the United States via IEGC in 2010. He was awarded Ernst & Young’s 2007 Australian Young Entrepreneur of the Year (Eastern Region). Mathieson is joined by Carla Cholewinski, who serves as chief operating officer with over 37 years of experience in the finance industry including banking, credit union management, regulatory oversight, debt securitization and underwriting.

IEG Holdings Corp. (IEGH), closed Monday's trading session at $0.255, even for the day, on 3,433 volume with 8 trades. The average volume for the last 60 days is 75,677 and the stock's 52-week low/high is $0.14/$4.19.

Recent News


PotNetwork Holding Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holding Inc. (POTN).

PotNetwork Holding, Inc. (OTC Pink:POTN) wholly owned subsidiary, Diamond CBD Inc., announced plans today to kick off its African business development strategy by co-sponsoring a series of community facing events in Kenya with their exclusive affinity marketing partner Exponential Inc. ("XPO2").

PotNetwork Holding, Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company’s First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holding.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies – Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies – Chill gummies are more robust than its counterpart, the “Relax” gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold – CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD – Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies – Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that’s looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet – CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf – Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD – Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot – CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it’s that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill – CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holding continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holding Inc. plans to expand its subsidiaries as well as make strategic acquisitions.

PotNetwork Holding Inc. (POTN), closed Monday's trading session at $0.291, off by 11.82%, on 7,656,300 volume with 1,341 trades. The average volume for the last 60 days is 12,097,492 and the stock's 52-week low/high is $0.0006/$0.957.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.